| Financial Year |
March 31 2023 |
| Monetary Funds |
3,575,889,904.16 |
| Held-for-trading Financial Assets |
8,356,564.57 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,692,430,074.94 |
| Advances to Suppliers |
277,912,275.47 |
| Other Receivables |
285,994,961.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,024,566.65 |
| Inventories |
3,789,379,593.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
101,687,860.73 |
| Total Current Assets |
9,741,922,407.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
84,576,672.78 |
| Investment Properties |
37,576,246.90 |
| Fixed Assetes |
871,865,755.24 |
| Under-construction Projects |
574,759.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
162,001,145.77 |
| R&D expenses |
-- |
| Goodwill |
1,397,180,502.63 |
| Long-Term Deferred and Prepaid Expenses |
646,833,534.73 |
| Deferred Income Tax Assets |
99,415,058.77 |
| Other Non-Current Assets |
275,267,978.88 |
| Sub-Total of Non-Current Assets |
6,674,476,886.11 |
| Total Assets |
16,416,399,293.13 |
| Short-Term Loans |
452,529,042.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,792,150,091.05 |
| Accounts Payable |
2,664,223,493.38 |
| Accounts Received In Advance |
9,524,241.57 |
| Employee Compensation Payable |
257,599,883.05 |
| Taxes Payable |
201,010,205.91 |
| Interest Payable |
-- |
| Dividend Payable |
27,031,285.33 |
| Other payables |
434,368,996.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
731,214,250.68 |
| Other Current Liabilities |
14,483,336.84 |
| Sub-Total of Current Liabilities |
6,705,872,270.63 |
| Long-term Loans |
2,004,520.54 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,039,367.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,939,057,845.01 |
| Total Liabilities |
8,644,930,115.64 |
| Paid-In Capital(Or Share Stock) |
596,023,425.00 |
| Capital Surplus |
2,142,777,551.36 |
| Surplus Reserve |
364,289,986.72 |
| LESS:Treasury Stock |
18,213,757.53 |
| Undistributed Profits |
4,574,848,241.10 |
| Minority Stockholder's Interest |
105,613,342.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,665,855,834.51 |
| Owner's Equity（Stockholder's Equity） |
7,771,469,177.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,416,399,293.13 |
